Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence
Pathology International · 2025-07 · 75 (7) · 340-348
DOI: 10.1111/pin.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, online erschienen am 14.05.2025. Verfasst von Ayuna Sugai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Pathology, National Defense Medical College, Tokorozawa, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Hepatitis A Virus Cellular Receptor 1, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kidney injury molecule‐1 (KIM‐1) is a potential prognostic marker of advanced‐stage clear cell renal cell carcinoma (ccRCC) and is associated with tumor immunogenicity. Little is known about its role in early‐stage ccRCC, especially in pathological T1b (pT1b) disease, which shows a higher recurrence rate than pT1a disease. Resected specimens from 112 pT1b ccRCC cases were reviewed and immunohistochemically analyzed for KIM‐1 expression. High membranous KIM‐1 expression was defined as H score ≥ 140, based on the immunoreactive intensity and area, and cytoplasmic expression in ≥ 10% of cancer cells was considered as high cytoplasmic KIM‐1 expression. KIM‐1 expression status was compared with clinicopathological variables, including tumor‐associated immune cell (TAIC) status. Among the 112 cases, high membranous and cytoplasmic KIM‐1 expression was observed in 30 (27%) and 38 (34%) cases, respectively. High membranous KIM‐1 expression was significantly associated with a higher nuclear grade, tumor necrosis, hot TAIC status, and shorter recurrence‐free survival (RFS) and cancer‐specific survival, whereas high cytoplasmic expression was only related to a higher nuclear grade. Multivariate Cox regression analysis revealed that high membranous KIM‐1 expression and tumor necrosis were independent predictors of shorter RFS. Our results indicate that membranous KIM‐1 expression could be a biomarker for predicting postnephrectomy recurrence in pT1b ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Pathology, National Defense Medical College, Tokorozawa, Japan.
- Department of Laboratory Medicine, National Defense Medical College Hospital, National Defense Medical College, Tokorozawa, Japan.
- Department of Urology, National Defense Medical College, Tokorozawa, Japan.
ORCID-Profile: Kosuke Miyai
Zitieren
APA
Sugai, A., Miyai, K., Ito, K., Matsukuma, S., & Sato, K. (2025). Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence. Pathology International, 75(7), 340-348. https://doi.org/10.1111/pin.70024
Vancouver
Sugai A, Miyai K, Ito K, Matsukuma S, Sato K. Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence. Pathology International. 2025;75(7):340-348. doi:10.1111/pin.70024
BibTeX
@article{Sugai2025,
author = {Sugai, Ayuna and Miyai, Kosuke and Ito, Keiichi and Matsukuma, Susumu and Sato, Kimiya},
title = {Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence},
journal = {Pathology International},
year = {2025},
volume = {75},
number = {7},
pages = {340--348},
doi = {10.1111/pin.70024}
}
EUVIMED